The 16 linked references in paper V. Lesnyak N., L. Anan'eva P., O. Koneva A., D. Goryachev V., E. Zvezdkina A., M. Kochanova N., O. Desinova V., O. Ovsyannikova B., M. Starovoytova N., В. Лесняк Н., Л. Ананьева П., О. Конева А., Д. Горячев В., Е. Звездкина А., М. Кочанова Н., О. Десинова В., О. Овсянникова Б., М. Старовойтова Н. (2017) “Полуколичественные визуальные методы оценки выраженности интерстициальных поражений легких по данным компьютерной томографии при системной склеродермии // Semi-quantification image methods for assessing severity of scleroderma-associated interstitial lung disease according to computed tomography data” / spz:neicon:pulmonology:y:2017:i:1:p:41-50

  1. American Thoracic Society / European Resperatory Society International Multidisciplinary Consensus Classification of the Idiopatic Interstitial Pneumanias. Am. J. Respir. Crit. Care Med.2002; 165 (2): 277–304. DOI: 10.1164/ajrccm. 165.2.ats01.
  2. Goldin J.G., Lynch D.A., Strollo D.C. et al. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest. 2008; 134 (2): 358–367. DOI: 10.1378/chest.07-2444.
  3. Afeltra A., Zennaro D., Garzia P. et al. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scan. J. Rheumatol. 2006; 35 (5): 388–394. DOI: 10.1080/03009740600844381.
  4. Steen V.D., Medsger T.A. Changes in causes of death in systemic sclerosis, 1972–2002. Ann. Rheum. Dis.2007; 66 (7): 940–944. DOI: 10.1136/ard.2006.066068.
  5. Bouros D., Wells A.U., Nicholson A.G. et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am. J. Respir. Crit. Care Med. 2002; 165 (12): 1581–1586. DOI: 10.1164/rccm.2106012.
  6. Goldin J.G., Lynch D.A., Strollo D.C. et al. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest. 2008; 134 (2): 358–367. DOI: 10.1378/chest.07-2444.
  7. Goh N.S., Desai S.R., Veeraraghavan S. et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am. J. Respir. Crit. Care Med. 2008; 177 (11): 1248–1254. DOI: 10.1164/rccm.200706-877OC.
  8. Goldin J., Elashoff R., Kim H.J. et al. Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study. Chest. 2009; 136 (5):1333–1340. DOI: 10.1378/chest.09-0108.
  9. Tochimoto A., Kawazuchi Y., Hara M. et al. Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral ptednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up. Mod. Rheumatol. 2011; 21 (3): 296–301. DOI: 10.1007/s10165-010-0403-6.
  10. Moore O.A., Goh N., Corte T. et al. Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology(Oxford). 2013; 52 (1): 155–160. DOI: 10.1093/rheumatology/kes289.
  11. Kazerooni E.A., Martinez F.J., Flint A. et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring.Am. J. Roentgenol.1997; 169 (4): 977–983. DOI: 10.2214/ajr.169.4.9308447.
  12. Hoogen F., Khanna D., Fransen J. et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology / European League against Rheumatism collaborative initiative. Arthritis Rheum.2013; 65 (11): 2737–2747. DOI: 10.1002/art.38098.
  13. Smidt N., Rutjes A., van der Windt al. Reproducibility of the STRAD checklist: an instrument to assess the quality of reporting of diagnostic accuracy studies.BMC Med. Res. Methodol. 2006; 6: 12. DOI:10.1186/1471-2288-6-12.
  14. Desai S.R., Veeraraghavan S., Hansell D.M. at al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004; 232 (2): 560–567. DOI: 10.1148/radiol.2322031223.
  15. Camiciotolli G., Orlandi I., Bartolucci M. et al. Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest. 2007; 131 (3): 672–681. DOI: 10.1378/chest.06-1401.
  16. Assayag D., Kaduri S., Hudson M. et al. High resolution computed tomography scoring systems for evaluating interstitial lung disease in systemic sclerosis patients. Rheuma( tology. 2012; S1: 003. DOI: 10.4172/2161-1149.S1-003. Поступила 09.02.16